Related references
Note: Only part of the references are listed.Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants
Eugenio Galli et al.
BONE MARROW TRANSPLANTATION (2022)
Clinical Significance of Haplo-Fever and Cytokine Profiling After Graft Infusion in Allogeneic Stem Cell Transplantation From Haplo-Identical Donors
Lining Wang et al.
FRONTIERS IN MEDICINE (2022)
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
Arnon Nagler et al.
HAEMATOLOGICA (2021)
PTCy and The Story of the Three Bears
Vedran Radojcic et al.
BONE MARROW TRANSPLANTATION (2021)
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu et al.
BLOOD (2021)
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
Shannon R. McCurdy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
Annalisa Ruggeri et al.
HAEMATOLOGICA (2017)
Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
Annalisa Ruggeri et al.
HAEMATOLOGICA (2017)
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Robert J. Soiffer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission
Kyoo-Hyung Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
Yvette L. Kasamon et al.
BLOOD ADVANCES (2017)
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Irwin Walker et al.
LANCET ONCOLOGY (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Nicolaus Kroeger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan
Kazuhiro Ikegame et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Yu Wang et al.
BLOOD (2015)
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Comparison of Allogeneic Stem Cell Transplantation from Familial-Mismatched/Haploidentical Donors and from Unrelated Donors in Adults with High-Risk Acute Myelogenous Leukemia
Byung-Sik Cho et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
Kyoo-Hyung Lee et al.
BLOOD (2011)
HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Hematopoietic Cell Transplantation from an HLA-Mismatched Familial Donor Is Feasible Without Ex Vivo-T Cell Depletion after Reduced-intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin
Kyoo-Hyung Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
Takakazu Kawase et al.
BLOOD (2007)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning
Hiroyasu Ogawa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients
SJ Choi et al.
BONE MARROW TRANSPLANTATION (2003)
Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin
J Finke et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
GB Ferrara et al.
BLOOD (2001)
Engraftment syndrome following hematopoietic stem cell transplantation
TR Spitzer
BONE MARROW TRANSPLANTATION (2001)
Share Paper
